Ideaya Biosciences Inc (IDYA)

BNP Paribas Financial Markets Buys 155,179 Shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA) - MarketBeat

MarketBeat

BNP Paribas Financial Markets Acquires 155179 Shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA) - Defense World

Defense World

RBC Capital Maintains Ideaya Biosciences (IDYA) Outperform Recommendation - MSN

MSN

Oppenheimer Maintains Ideaya Biosciences (IDYA) Outperform Recommendation - MSN

MSN

Ready to Jump After Recent Trade: Ideaya Biosciences Inc (IDYA) – Sete News - SETE News

SETE News

IDEAYA Biosciences, Inc. (NASDAQ:IDYA) CEO Sells $1,439,643.73 in Stock - MarketBeat

MarketBeat

IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Short Interest Update - Defense World

Defense World

IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Short Interest Update - MarketBeat

MarketBeat

Nicholas Investment Partners LP Invests $3.93 Million in IDEAYA Biosciences, Inc. (NASDAQ:IDYA) - MarketBeat

MarketBeat

The Goldman Sachs Group Lowers IDEAYA Biosciences (NASDAQ:IDYA) Price Target to $46.00 - Defense World

Defense World

The Goldman Sachs Group Lowers IDEAYA Biosciences (NASDAQ:IDYA) Price Target to $46.00 - MarketBeat

MarketBeat

How Many IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Shares Do Institutions Own? - Yahoo Lifestyle UK

Yahoo Lifestyle UK

Victory Capital Management Inc. Acquires Shares of 346,490 IDEAYA Biosciences, Inc. (NASDAQ:IDYA) - MarketBeat

MarketBeat

(IDYA) Investment Report - Stock Traders Daily

Stock Traders Daily

IDEAYA Biosciences (IDYA) Stock Forecast and Price Target 2024 - MarketBeat

MarketBeat

Q2 2024 Earnings Estimate for IDEAYA Biosciences, Inc. Issued By Wedbush (NASDAQ:IDYA) - Defense World

Defense World

Q2 2024 EPS Estimates for IDEAYA Biosciences, Inc. Decreased by Analyst (NASDAQ:IDYA) - MarketBeat

MarketBeat

New York State Common Retirement Fund Buys 20,185 Shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA) - MarketBeat

MarketBeat

New York State Common Retirement Fund Boosts Stock Position in IDEAYA Biosciences, Inc. (NASDAQ:IDYA) - Defense World

Defense World

Q1 2025 Earnings Estimate for IDEAYA Biosciences, Inc. Issued By Wedbush (NASDAQ:IDYA) - Defense World

Defense World

New York State Common Retirement Fund Buys 20,185 Shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA) - MarketBeat

MarketBeat

Brokers Issue Forecasts for IDEAYA Biosciences, Inc.'s Q1 2025 Earnings (NASDAQ:IDYA) - MarketBeat

MarketBeat

Ideaya Biosciences Inc (IDYA) is an excellent investment, but the stock is overvalued/undervalued right now – US Post ... - US Post News

US Post News

IDEAYA Biosciences (NASDAQ:IDYA) Announces Quarterly Earnings Results - MarketBeat

MarketBeat

Wedbush Reaffirms "Outperform" Rating for IDEAYA Biosciences (NASDAQ:IDYA) - MarketBeat

MarketBeat

IDEAYA Biosciences, Inc. (IDYA) Reports Q4 Loss, Lags Revenue Estimates - Yahoo Singapore News

Yahoo Singapore News

Unveiling 5 Analyst Insights On IDEAYA Biosciences - IDEAYA Biosciences (NASDAQ:IDYA) - Benzinga

Benzinga

Ideaya Biosciences reports Q1 EPS (53c), consensus (51c) - TipRanks.com - TipRanks

TipRanks

IDEAYA Biosciences First Quarter 2024 Earnings: US$0.53 loss per share (vs US$0.49 loss in 1Q 2023) - Yahoo Finance

Yahoo Finance

Wedbush Reaffirms "Outperform" Rating for IDEAYA Biosciences (NASDAQ:IDYA) - MarketBeat

MarketBeat

IDEAYA Biosciences, Inc. Reports First Quarter 2024 Financial Results and Provides Business Update - PR Newswire

PR Newswire

IDEAYA Biosciences, Inc. (IDYA) Reports Q1 Loss, Tops Revenue Estimates - Yahoo New Zealand News

Yahoo New Zealand News

Fisher Asset Management LLC Boosts Position in IDEAYA Biosciences, Inc. (NASDAQ:IDYA) - Defense World

Defense World

IDEAYA Biosciences, Inc. (IDYA) Reports Q4 Loss, Lags Revenue Estimates - Yahoo New Zealand News

Yahoo New Zealand News

How the (IDYA) price action is used to our Advantage - Stock Traders Daily

Stock Traders Daily

IDEAYA Biosciences to Participate in Upcoming May 2024 Investor Relations Event - Yahoo Finance

Yahoo Finance

IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - PR Newswire

PR Newswire

IDEAYA Biosciences Announces ASCO 2024 Oral Presentation for Darovasertib in Neoadjuvant Uveal Melanoma ... - Financial Times

Financial Times

IDEAYA Biosciences Announces ASCO 2024 Oral Presentation for Darovasertib in Neoadjuvant Uveal Melanoma ... - PR Newswire

PR Newswire

IDEAYA Biosciences Announces Selection of Move-Forward Phase 2 Expansion Dose for IDE397 Monotherapy in ... - PR Newswire

PR Newswire

Ideaya Biosciences announces inducement grants under Nasdaq listing rule - TipRanks.com - TipRanks

TipRanks

IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - Investing.com India

Investing.com India

IDEAYA and Merck enter collaboration for endometrial cancer trial - Clinical Trials Arena

Clinical Trials Arena

IDEAYA Announces Clinical Collaboration to Evaluate IDE161 in Combination with KEYTRUDA® (pembrolizumab) in ... - PR Newswire

PR Newswire

Demystifying IDEAYA Biosciences: Insights From 6 Analyst Reviews

Benzinga

IDYA Stock Quote Price and Forecast - CNN

CNN

IDEAYA Biosciences to Participate in Upcoming March 2024 Investor Relations Events - BioSpace

BioSpace

IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Analysts Are Pretty Bullish On The Stock After Recent Results - Yahoo Finance

Yahoo Finance

Is IDEAYA Biosciences (NASDAQ:IDYA) A Risky Investment? - Simply Wall St

Simply Wall St

The Analyst Verdict: IDEAYA Biosciences In The Eyes Of 6 Experts

Benzinga